Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
14434082 83369 11 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
CHEMBL2205801 83369 11 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
14434082 83369 11 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
CHEMBL2205801 83369 11 None -3 3 Human 4.8 pEC50 = 4.8 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
72791 206499 71 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL98682 206499 71 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
72791 206499 71 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL98682 206499 71 None -1 2 Human 5.7 pEC50 = 5.7 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cc2cccnc2c2ncccc12 10.1021/jm301121j
77865 106802 76 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL317115 106802 76 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
14338 4302 115 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4302 115 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
77865 106802 76 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
CHEMBL317115 106802 76 None 1 2 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 214 0 0 2 3.4 Clc1cc2cccnc2c2ncccc12 10.1021/jm301121j
14338 4302 115 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4302 115 None 3 3 Human 5.5 pEC50 = 5.5 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
667748 83372 78 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83372 78 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
12425 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
667748 83372 78 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83372 78 None 3 3 Human 6.4 pEC50 = 6.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
12425 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 116 None 1 4 Human 5.4 pEC50 = 5.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1474 153865 133 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 153865 133 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
1474 153865 133 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 153865 133 None -1 3 Human 4.4 pEC50 = 4.4 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
74265 206606 107 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
CHEMBL99384 206606 107 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
20445 83373 105 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
CHEMBL2205806 83373 105 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
70848 204945 105 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 204945 105 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
72792 198041 76 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 198041 76 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
74265 206606 107 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
CHEMBL99384 206606 107 None 2 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
20445 83373 105 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
CHEMBL2205806 83373 105 None 2 2 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1cccc(-c2cccc(C)n2)n1 10.1021/jm301121j
2733927 83375 90 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83375 90 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
70848 204945 105 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 204945 105 None 5 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
72792 198041 76 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 198041 76 None 5 3 Human 6.3 pEC50 = 6.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
2733927 83375 90 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83375 90 None 1 3 Human 5.3 pEC50 = 5.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
15783796 83378 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83378 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
93149 106717 78 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 106717 78 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
12987698 83376 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83376 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
15783796 83378 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83378 1 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
93149 106717 78 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 106717 78 None 1 3 Human 6.2 pEC50 = 6.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
12987698 83376 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83376 4 None -3 3 Human 5.2 pEC50 = 5.2 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
15664 83374 93 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83374 93 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
15664 83374 93 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83374 93 None -2 3 Human 5.1 pEC50 = 5.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
77524 55597 94 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
CHEMBL1623498 55597 94 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
77524 55597 94 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
CHEMBL1623498 55597 94 None - 1 Human 4.1 pEC50 = 4.1 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 212 0 2 4 2.2 Oc1ccnc2c1ccc1c(O)ccnc12 10.1021/jm301121j
10391001 136674 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374939 136674 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11541506 76163 0 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
CHEMBL205993 76163 0 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
16105860 136679 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 507 8 2 4 4.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(CC)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374978 136679 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 507 8 2 4 4.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(CC)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105782 82293 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 482 6 2 6 3.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccncc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217965 82293 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 482 6 2 6 3.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccncc3)c3ccccc23)CC1 10.1021/jm061118e
16112836 92933 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 92933 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in Th2 cells assessed as I309 mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439843 91109 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 426 4 1 4 4.9 O=C1OC(c2ccnc3ccccc23)CN1C1CCN(Cc2cc3ccccc3[nH]2)CC1 10.1016/j.bmcl.2006.12.076
CHEMBL240462 91109 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 426 4 1 4 4.9 O=C1OC(c2ccnc3ccccc23)CN1C1CCN(Cc2cc3ccccc3[nH]2)CC1 10.1016/j.bmcl.2006.12.076
16105780 84178 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 481 7 2 6 3.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cnccn3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222112 84178 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 481 7 2 6 3.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cnccn3)c3ccccc23)CC1 10.1021/jm061118e
44598057 195394 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 421 6 0 4 4.6 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL567419 195394 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 421 6 0 4 4.6 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11533398 75633 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
CHEMBL205447 75633 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
44457090 97213 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL271128 97213 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11950828 97172 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm070543k
CHEMBL270971 97172 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm070543k
11950828 97172 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm900713y
CHEMBL270971 97172 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cc[n+]([O-])cc1)CC2 10.1021/jm900713y
44457090 97213 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm070543k
CHEMBL271128 97213 1 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm070543k
44457009 158462 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm070543k
CHEMBL409648 158462 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccc(Cl)cc2)CC3)c1 10.1021/jm070543k
16105857 165649 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 479 7 2 4 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL426551 165649 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 479 7 2 4 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10480554 149682 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 485 5 0 5 5.7 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395211 149682 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 485 5 0 5 5.7 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439881 93367 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 0 6 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6o5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247563 93367 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 0 6 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6o5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10004785 93411 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 467 5 0 5 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247762 93411 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 467 5 0 5 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439890 93482 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 447 6 0 6 4.4 COc1ccc(CN2CCC(N3CC(c4ccnc5ccc(OC)cc45)OC3=O)CC2)cc1 10.1016/j.bmcl.2006.12.076
CHEMBL248171 93482 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 447 6 0 6 4.4 COc1ccc(CN2CCC(N3CC(c4ccnc5ccc(OC)cc45)OC3=O)CC2)cc1 10.1016/j.bmcl.2006.12.076
44439886 93443 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 417 5 0 5 4.4 COc1ccc2nccc(C3CN(C4CCN(Cc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247964 93443 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 417 5 0 5 4.4 COc1ccc2nccc(C3CN(C4CCN(Cc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439895 149933 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 442 5 0 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C#N)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395423 149933 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 442 5 0 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C#N)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16065425 195552 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 405 3 0 4 3.9 CC1Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)c2O1 10.1021/jm900713y
CHEMBL568296 195552 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 405 3 0 4 3.9 CC1Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)c2O1 10.1021/jm900713y
16105885 82361 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 580 11 2 6 5.0 CCN(CC)CCCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217984 82361 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 580 11 2 6 5.0 CCN(CC)CCCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
44598821 196261 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
CHEMBL573216 196261 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
44598059 195337 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
CHEMBL566974 195337 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
44598769 195423 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 422 6 0 5 4.0 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
CHEMBL567620 195423 1 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 422 6 0 5 4.0 CC(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncn1)CC2 10.1021/jm900713y
16105854 83498 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 8 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220650 83498 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 8 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
16065428 196181 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 391 3 0 4 3.5 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc4c3OCC4)CC2)CC1 10.1021/jm900713y
CHEMBL572537 196181 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 391 3 0 4 3.5 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc4c3OCC4)CC2)CC1 10.1021/jm900713y
16105774 83907 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 10 2 4 5.5 CCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL221601 83907 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 10 2 4 5.5 CCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
3384970 160734 8 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL412116 160734 8 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
16105862 82976 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 469 7 2 5 3.8 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccoc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219432 82976 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 469 7 2 5 3.8 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccoc3)c3ccccc23)CC1 10.1021/jm061118e
44439837 147444 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 430 8 2 5 4.4 COc1ccc2nccc(C3CN(CCCNCc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL393411 147444 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 430 8 2 5 4.4 COc1ccc2nccc(C3CN(CCCNCc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44457089 97212 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccn1)CC2 10.1021/jm070543k
CHEMBL271127 97212 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 471 6 0 5 5.4 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccccn1)CC2 10.1021/jm070543k
11950826 158643 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 457 5 0 4 4.6 O=C(c1cc[n+]([O-])cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL409849 158643 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 457 5 0 4 4.6 O=C(c1cc[n+]([O-])cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44456993 97338 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL271801 97338 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
44456993 97338 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL271801 97338 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44598060 195590 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 0 5 4.1 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccncn3)CC4)ccc2O1 10.1021/jm900713y
CHEMBL568503 195590 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 0 5 4.1 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccncn3)CC4)ccc2O1 10.1021/jm900713y
44457046 166781 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL429436 166781 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44457046 166781 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL429436 166781 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
16105772 82960 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3F)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219380 82960 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3F)c3ccccc23)CC1 10.1021/jm061118e
16105819 84069 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 622 9 2 7 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CC(C)OC(C)C3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL222020 84069 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 622 9 2 7 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CC(C)OC(C)C3)CC2)c2ccccc12 10.1021/jm061118e
16112836 92933 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 92933 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
45483901 195393 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 6 1 5 5.1 CCCC1(CC)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL567417 195393 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 6 1 5 5.1 CCCC1(CC)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
16064872 195595 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)c2O1 10.1021/jm900713y
CHEMBL568523 195595 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)c2O1 10.1021/jm900713y
44598124 196961 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 470 3 1 5 4.4 CC1(C)Oc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2C1(F)F 10.1021/jm900713y
CHEMBL579072 196961 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 470 3 1 5 4.4 CC1(C)Oc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2C1(F)F 10.1021/jm900713y
45483880 195551 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 3 1 5 4.9 CC(C)(C)C1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL568294 195551 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 476 3 1 5 4.9 CC(C)(C)C1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
16105859 83912 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(F)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221639 83912 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(F)c3)c3ccccc23)CC1 10.1021/jm061118e
16105864 83946 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 483 7 2 6 2.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3nccn3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221842 83946 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 483 7 2 6 2.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3nccn3C)c3ccccc23)CC1 10.1021/jm061118e
16105855 82730 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 487 7 2 5 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCOCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218209 82730 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 487 7 2 5 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCOCC3)c3ccccc23)CC1 10.1021/jm061118e
11584004 140167 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
CHEMBL381619 140167 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
45483913 195254 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ncccc3N)CC4)c2O1 10.1021/jm900713y
CHEMBL566324 195254 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ncccc3N)CC4)c2O1 10.1021/jm900713y
44598121 195424 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL567627 195424 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)cccc2O1 10.1021/jm900713y
16105777 136436 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 5 5.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc4ccccc4s3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374414 136436 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 5 5.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc4ccccc4s3)c3ccccc23)CC1 10.1021/jm061118e
16105776 136412 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 585 10 2 5 5.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(OCc4ccccc4)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374274 136412 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 585 10 2 5 5.7 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(OCc4ccccc4)cc3)c3ccccc23)CC1 10.1021/jm061118e
9911916 91247 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL240848 91247 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10433657 93444 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 7 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CCCc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247965 93444 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 7 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CCCc5ccccc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11842667 160499 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cccc[n+]2[O-])CC3)c1 10.1021/jm070543k
CHEMBL411651 160499 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cccc[n+]2[O-])CC3)c1 10.1021/jm070543k
44456948 159570 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
CHEMBL410885 159570 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm070543k
44456948 159570 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
CHEMBL410885 159570 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 442 5 0 5 4.8 O=C(c1ccncn1)N1CCC2(CCN(Cc3cccc(Oc4ccccc4)c3)CC2)CC1 10.1021/jm900713y
16105887 83929 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 640 9 2 6 5.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCc4ccccc4C3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221712 83929 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 640 9 2 6 5.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCc4ccccc4C3)CC2)c2ccccc12 10.1021/jm061118e
16105865 168775 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 494 7 2 5 3.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL441870 168775 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 494 7 2 5 3.9 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3C)c3ccccc23)CC1 10.1021/jm061118e
16065567 197148 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 3 0 4 4.3 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL583621 197148 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 3 0 4 4.3 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccncc3)CC4)cccc2O1 10.1021/jm900713y
10479253 91108 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 1 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2n1 10.1016/j.bmcl.2006.12.076
CHEMBL240461 91108 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 457 5 1 6 4.3 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2n1 10.1016/j.bmcl.2006.12.076
44439883 93410 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 468 5 0 6 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6n5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247761 93410 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 468 5 0 6 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc6ccccc6n5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10412437 150797 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 470 5 0 6 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6n5C)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL396102 150797 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 470 5 0 6 4.9 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6n5C)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11951000 97373 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm900713y
CHEMBL272022 97373 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm900713y
44457093 97329 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
CHEMBL271768 97329 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 441 5 0 4 5.4 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
11951000 97373 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm070543k
CHEMBL272022 97373 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2cc[n+]([O-])cc2)CC3)c1 10.1021/jm070543k
44457105 158068 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm070543k
CHEMBL409224 158068 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm070543k
44457105 158068 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm900713y
CHEMBL409224 158068 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 504 6 0 4 6.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc(Cl)cc1)CC2 10.1021/jm900713y
16105775 82975 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 549 11 2 4 5.9 CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL219431 82975 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 549 11 2 4 5.9 CCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCN(C(=O)CCC)CC3)c3ccccc23)cc1 10.1021/jm061118e
16105868 137513 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 471 7 2 4 4.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376517 137513 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 471 7 2 4 4.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCC3)c3ccccc23)CC1 10.1021/jm061118e
16105867 137341 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 443 7 2 4 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376071 137341 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 443 7 2 4 3.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CC3)c3ccccc23)CC1 10.1021/jm061118e
16105863 83914 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 539 7 2 6 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C(C)(C)C)nn3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221650 83914 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 539 7 2 6 4.2 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C(C)(C)C)nn3C)c3ccccc23)CC1 10.1021/jm061118e
10003657 152298 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 5 0 5 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C)c(C)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL397395 152298 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 445 5 0 5 5.0 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(C)c(C)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
11685733 139672 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL380492 139672 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105817 136448 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 578 9 2 6 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL374527 136448 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 578 9 2 6 4.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
44598058 196455 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccncn2)CC3)c1 10.1021/jm900713y
CHEMBL574655 196455 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 472 6 0 6 4.8 COc1ccccc1Oc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccncn2)CC3)c1 10.1021/jm900713y
16105781 82747 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccn3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218298 82747 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccn3)c3ccccc23)CC1 10.1021/jm061118e
11526626 75191 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL204419 75191 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105779 136677 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 528 7 2 5 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)nc(Cl)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374964 136677 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 528 7 2 5 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)nc(Cl)c3)c3ccccc23)CC1 10.1021/jm061118e
16105778 82185 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 551 7 2 5 5.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)oc3C(F)(F)F)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL217909 82185 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 551 7 2 5 5.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cc(C)oc3C(F)(F)F)c3ccccc23)CC1 10.1021/jm061118e
16105858 83942 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(C)c3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221790 83942 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccc(C)c3)c3ccccc23)CC1 10.1021/jm061118e
44598062 195594 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 446 3 1 5 4.4 CC1(C)C=Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
CHEMBL568522 195594 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 446 3 1 5 4.4 CC1(C)C=Cc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
10255258 149935 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 495 5 0 5 5.2 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Br)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL395424 149935 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 495 5 0 5 5.2 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Br)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16112836 92933 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL245568 92933 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assayAntagonist activity at human recombinant CCR8 expressed in HUT78 cells assessed as I309-mediated migration by chemotaxis assay
ChEMBL 456 5 1 5 4.9 COc1ccc2nccc([C@@H]3CN(C4CCN(Cc5cc6ccccc6[nH]5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
10409369 168938 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 411 8 0 5 4.8 CCCCCCN1CCC(N2CC(c3ccnc4ccc(OC)cc34)OC2=O)CC1 10.1016/j.bmcl.2006.12.076
CHEMBL443315 168938 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 411 8 0 5 4.8 CCCCCCN1CCC(N2CC(c3ccnc4ccc(OC)cc34)OC2=O)CC1 10.1016/j.bmcl.2006.12.076
44598820 197103 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 465 6 0 4 4.8 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3OC(F)(F)C(F)F)CC2)CC1 10.1021/jm900713y
CHEMBL583212 197103 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 465 6 0 4 4.8 O=C(c1ccncc1)N1CCC2(CCN(Cc3ccccc3OC(F)(F)C(F)F)CC2)CC1 10.1021/jm900713y
11965686 197177 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 1 5 4.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc[nH]c1=O)CC2 10.1021/jm900713y
CHEMBL583843 197177 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 487 6 1 5 4.7 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccc[nH]c1=O)CC2 10.1021/jm900713y
11539239 77772 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
CHEMBL210322 77772 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
11519336 77523 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL209350 77523 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8Inhibition of I309-induced chemotaxis in L1.2 cells expressing CCR8
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105783 82798 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 457 7 2 4 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218554 82798 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 457 7 2 4 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCC3)c3ccccc23)CC1 10.1021/jm061118e
16105773 83989 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(F)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221978 83989 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 497 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(F)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105784 83903 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 7 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221586 83903 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 485 7 2 4 4.4 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
16065704 197195 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 436 3 1 6 3.7 CC1(C)Oc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
CHEMBL584087 197195 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 436 3 1 6 3.7 CC1(C)Oc2cccc(CN3CCC4(CC3)CCN(C(=O)c3ccnc(N)c3)CC4)c2O1 10.1021/jm900713y
16105861 82746 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 4 5.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C(C)(C)C)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218297 82746 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 535 7 2 4 5.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C(C)(C)C)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105787 83499 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC(C)(C)C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220651 83499 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 7 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)CC(C)(C)C)c3ccccc23)CC1 10.1021/jm061118e
10343818 150826 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL396124 150826 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5ccc(Cl)cc5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439838 90932 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 444 8 1 5 4.7 COc1ccc2nccc(C3CN(CCCN(C)Cc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL240249 90932 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 444 8 1 5 4.7 COc1ccc2nccc(C3CN(CCCN(C)Cc4cc5ccccc5[nH]4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439887 93481 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cccc(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL248169 93481 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 451 5 0 5 5.1 COc1ccc2nccc(C3CN(C4CCN(Cc5cccc(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439909 166968 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 499 4 0 5 5.3 COc1ccc2nccc(C3CN(C4CCN(C(=O)c5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL430012 166968 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 499 4 0 5 5.3 COc1ccc2nccc(C3CN(C4CCN(C(=O)c5ccc(Cl)c(Cl)c5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16105786 141175 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 9 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)CC)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL385654 141175 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 473 9 2 4 4.3 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)CC)c3ccccc23)CC1 10.1021/jm061118e
16105856 83500 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 521 9 2 4 5.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220652 83500 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 521 9 2 4 5.0 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)C(CC)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
44598819 195317 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 6 0 4 4.6 C=C(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
CHEMBL566759 195317 1 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 419 6 0 4 4.6 C=C(C)COc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1ccncc1)CC2 10.1021/jm900713y
11950827 97171 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cccc[n+]1[O-])CC2 10.1021/jm070543k
CHEMBL270969 97171 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 487 6 0 5 4.6 COc1ccccc1Oc1ccccc1CN1CCC2(CC1)CCN(C(=O)c1cccc[n+]1[O-])CC2 10.1021/jm070543k
10412573 93368 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 473 5 0 6 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6s5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247564 93368 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 473 5 0 6 5.6 COc1ccc2nccc(C3CN(C4CCN(Cc5cc6ccccc6s5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
44439885 93442 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 423 5 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CC5CCCCC5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
CHEMBL247963 93442 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assayAntagonist activity at human recombinant CCR8 expressed in RBL cells assessed as inhibition of I-309-induced intracellular calcium mobilization by FLIPR assay
ChEMBL 423 5 0 5 4.8 COc1ccc2nccc(C3CN(C4CCN(CC5CCCCC5)CC4)C(=O)O3)c2c1 10.1016/j.bmcl.2006.12.076
16065569 195292 20 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
CHEMBL566543 195292 20 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 434 3 1 5 3.9 CC1(C)Cc2c(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)cccc2O1 10.1021/jm900713y
11273324 95462 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
CHEMBL259243 95462 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR8 receptorAntagonist activity at CCR8 receptor
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm070543k
11273324 95462 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
CHEMBL259243 95462 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 474 5 0 3 6.7 O=C(c1ccc(Cl)cc1)N1CCC2(CCN(Cc3ccccc3Oc3ccccc3)CC2)CC1 10.1021/jm900713y
16105866 82799 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218555 82799 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 480 7 2 5 3.6 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3cccnc3)c3ccccc23)CC1 10.1021/jm061118e
16105771 84135 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)cc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222062 84135 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)cc3)c3ccccc23)CC1 10.1021/jm061118e
16105815 82765 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 552 9 2 6 4.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218369 82765 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assayAntagonist activity against human CCR8 expressed in CHO/Galpha16 cells assessed as inhibition of CCL1-induced increase of intracellular calcium by FLIPR assay
ChEMBL 552 9 2 6 4.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)OCCCN(C)C)CC2)c2ccccc12 10.1021/jm061118e
44598061 195362 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 448 3 1 5 4.3 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)ccc2O1 10.1021/jm900713y
CHEMBL567202 195362 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR8Antagonist activity at human CCR8
ChEMBL 448 3 1 5 4.3 CC1(C)CCc2cc(CN3CCC4(CC3)CCN(C(=O)c3ccc(N)cn3)CC4)ccc2O1 10.1021/jm900713y
15664 83374 93 None -2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
CHEMBL2205807 83374 93 None -2 3 Human 8.3 pEC50 = 8.3 Functional
Allosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR8 transfected in COS7 cells assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
486830 3939 0 None -10 5 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
768 3939 0 None -10 5 Human 8.1 pIC50 = 8.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
812 810 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
812 810 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11154210
812 810 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16221874
815 3938 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
815 3938 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11154210
816 3937 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10419462
11688990 4083 0 None - 1 Human 5.7 pIC50 None 5.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874
813 4083 0 None - 1 Human 5.7 pIC50 None 5.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874
CHEMBL1883966 4083 0 None - 1 Human 5.7 pIC50 None 5.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 356 9 1 5 2.6 OCCOCCN1CCN(CC1)Cc1cccc(c1)Oc1ccccc1 16221874




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
155557362 174071 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assay
ChEMBL 560 6 1 6 5.4 CC[C@]12C=C(C(=O)OC)n3c(c(CCNC(=O)c4ccc(Br)cc4)c4ccccc43)[C@H]1N(C#N)CCC2 10.1021/acs.jmedchem.9b01924
CHEMBL4558185 174071 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Antagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHOK1 cells assessed as reduction in CCL1-induced beta-arrestin 2 recruitment incubated for 30 mins followed by CCL1 addition and measured after 90 or 180 mins by pathhunter beta-arrestin assay
ChEMBL 560 6 1 6 5.4 CC[C@]12C=C(C(=O)OC)n3c(c(CCNC(=O)c4ccc(Br)cc4)c4ccccc43)[C@H]1N(C#N)CCC2 10.1021/acs.jmedchem.9b01924
132072454 179144 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
CHEMBL4744046 179144 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR8 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
10367938 82766 0 None - 1 Human 9.8 pKi = 9.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218374 82766 0 None - 1 Human 9.8 pKi = 9.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10391001 136674 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL374939 136674 0 None - 1 Human 9.5 pKi = 9.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 493 7 2 4 4.5 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11754900 83948 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 5 3 4 3.5 CNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221865 83948 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 5 3 4 3.5 CNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
10006907 141282 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL386308 141282 0 None - 1 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
10006907 141282 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL386308 141282 0 None - 1 Human 9.0 pKi = 9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 6 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)[C@@H]3CCCN3)CC2)c2ccccc12 10.1021/jm061118e
9984180 136026 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 5 2 4 4.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL373739 136026 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 520 5 2 4 4.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
16105811 137144 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 6 3 5 2.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CNC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL375854 137144 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 6 3 5 2.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CNC3)CC2)c2ccccc12 10.1021/jm061118e
16105788 82767 6 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL218375 82767 6 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105880 83950 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 8 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221867 83950 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 8 3 5 3.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN)CC2)c2ccccc12 10.1021/jm061118e
16105822 137631 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 5 2 4 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL376910 137631 0 None - 1 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 5 2 4 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N(C)C)CC2)c2ccccc12 10.1021/jm061118e
16105890 141414 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 542 6 3 4 5.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)Nc3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL387161 141414 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 542 6 3 4 5.4 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)Nc3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
11519336 77523 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL209350 77523 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 527 9 1 5 5.6 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4OC)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105807 83558 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 7 3 5 3.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL220703 83558 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 7 3 5 3.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCN)CC2)c2ccccc12 10.1021/jm061118e
16105813 83829 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 570 7 2 5 5.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccc(N(C)C)cc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221078 83829 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 570 7 2 5 5.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccc(N(C)C)cc3)CC2)c2ccccc12 10.1021/jm061118e
16105831 83001 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 488 5 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)N3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219589 83001 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 488 5 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)N3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
11502217 75682 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 400 7 1 3 4.8 O=C(Cc1ccccc1)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205692 75682 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 400 7 1 3 4.8 O=C(Cc1ccccc1)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11526626 75191 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL204419 75191 0 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 531 8 1 4 6.3 CCN1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105760 137342 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 509 5 2 5 4.8 CC(C)(C)OC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL376076 137342 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 509 5 2 5 4.8 CC(C)(C)OC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
16105805 83984 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 7 2 5 3.3 COCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221961 83984 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 7 2 5 3.3 COCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105799 165593 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 482 6 1 6 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL426207 165593 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 482 6 1 6 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OC(=O)c3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
11774008 84176 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 402 5 2 3 4.9 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL222110 84176 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 402 5 2 3 4.9 O=C(Nc1ccc(S(=O)(=O)Nc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105809 83911 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 522 9 3 5 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCCN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221638 83911 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 522 9 3 5 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCCN)CC2)c2ccccc12 10.1021/jm061118e
16105889 83557 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 6 3 4 3.9 CCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220701 83557 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 494 6 3 4 3.9 CCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
9982672 82413 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2cccc3c(NC(=O)c4ccccc4)cccc23)CC1 10.1021/jm061118e
CHEMBL218037 82413 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2cccc3c(NC(=O)c4ccccc4)cccc23)CC1 10.1021/jm061118e
16105802 83651 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 6 2 4 4.1 CCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL220753 83651 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 6 2 4 4.1 CCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105895 141386 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc3cccc(NC(=O)c4ccccc4)c3c2)CC1 10.1021/jm061118e
CHEMBL386987 141386 0 None - 1 Human 5.7 pKi = 5.7 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 2 5 4.0 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc3cccc(NC(=O)c4ccccc4)c3c2)CC1 10.1021/jm061118e
11563243 168135 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CCN1CCC(C(=O)NC2(C(=O)O)CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL436753 168135 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CCN1CCC(C(=O)NC2(C(=O)O)CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
11270007 84177 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 416 6 2 3 4.6 O=C(Nc1ccc(S(=O)(=O)NCc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL222111 84177 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 416 6 2 3 4.6 O=C(Nc1ccc(S(=O)(=O)NCc2ccccc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105888 135851 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 466 5 3 4 3.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(N)=O)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL373504 135851 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 466 5 3 4 3.2 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(N)=O)CC2)c2ccccc12 10.1021/jm061118e
11541073 75637 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 532 8 1 4 7.1 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccc(Cl)cc4)CCCCC3)CC2)c1 10.1021/jm050965z
CHEMBL205457 75637 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 532 8 1 4 7.1 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccc(Cl)cc4)CCCCC3)CC2)c1 10.1021/jm050965z
11539239 77772 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
CHEMBL210322 77772 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 430 8 1 4 4.8 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)Cc3ccccc3)CC2)c1 10.1021/jm050965z
792361 75838 7 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 339 6 0 4 4.3 CCOC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205808 75838 7 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 339 6 0 4 4.3 CCOC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11584004 140167 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
CHEMBL381619 140167 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 489 7 2 4 5.1 O=C(NC1CCN(Cc2cccc(Oc3ccccc3Cl)c2)CC1)C1(c2ccccc2)CCNC1 10.1021/jm050965z
16105891 83835 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 5 2 4 4.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221130 83835 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 506 5 2 4 4.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCC3)CC2)c2ccccc12 10.1021/jm061118e
44419035 83865 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 9 2 5 4.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221345 83865 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 9 2 5 4.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
11384528 141100 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 417 6 2 4 4.0 O=C(Nc1ccc(S(=O)(=O)NCc2ccncc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL385287 141100 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 417 6 2 4 4.0 O=C(Nc1ccc(S(=O)(=O)NCc2ccncc2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105832 82948 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 7 2 4 4.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
CHEMBL219327 82948 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 479 7 2 4 4.1 CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
44419032 84134 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 8 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL222058 84134 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 8 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
16105840 83941 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 468 7 1 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221789 83941 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 468 7 1 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(OCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10254576 83956 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 6 3 5 2.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CN)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221904 83956 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 480 6 3 5 2.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CN)CC2)c2ccccc12 10.1021/jm061118e
16105824 83854 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 549 5 2 5 3.5 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCN(C)CC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL221251 83854 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 549 5 2 5 3.5 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCN(C)CC3)CC2)c2ccccc12 10.1021/jm061118e
16105892 141075 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 534 5 2 4 4.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL385108 141075 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 534 5 2 4 4.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCCCC3)CC2)c2ccccc12 10.1021/jm061118e
11452569 82788 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 408 5 2 3 4.7 O=C(Nc1ccc(S(=O)(=O)NC2CCCCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL218503 82788 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 408 5 2 3 4.7 O=C(Nc1ccc(S(=O)(=O)NC2CCCCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
3384970 160734 8 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
CHEMBL412116 160734 8 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 432 6 2 4 4.9 COc1ccc(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3)c3ccccc23)cc1 10.1021/jm061118e
44419031 137177 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 467 7 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL375880 137177 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 467 7 2 5 4.4 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(NCc3ccccc3)c3ccccc23)CC1 10.1021/jm061118e
10391077 136859 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)Nc3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL375315 136859 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 495 6 2 5 4.3 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)Nc3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105877 82412 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 3 5 2.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CO)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218036 82412 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 481 6 3 5 2.7 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CO)CC2)c2ccccc12 10.1021/jm061118e
16105844 82359 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 7 2 4 3.7 CCCC(=O)N1CC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
CHEMBL217979 82359 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 7 2 4 3.7 CCCC(=O)N1CC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)C1 10.1021/jm061118e
16105830 82985 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 564 11 2 5 4.8 CCN(CC)CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL219487 82985 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 564 11 2 5 4.8 CCN(CC)CCCC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11235229 83000 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 409 5 3 4 3.1 O=C(Nc1ccc(S(=O)(=O)NC2CCNCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL219588 83000 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 409 5 3 4 3.1 O=C(Nc1ccc(S(=O)(=O)NC2CCNCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
11541506 76163 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
CHEMBL205993 76163 0 None - 1 Human 8.2 pKi = 8.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 575 9 2 5 5.7 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)C1 10.1021/jm050965z
16105893 82734 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 536 5 2 5 3.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218218 82734 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 536 5 2 5 3.6 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)N3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
16105803 83988 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 5 2 4 3.7 CC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221977 83988 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 465 5 2 4 3.7 CC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
11706579 139207 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 543 9 3 6 4.3 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)(C(=O)O)CC2)c1 10.1021/jm050965z
CHEMBL379834 139207 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 543 9 3 6 4.3 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)(C(=O)O)CC2)c1 10.1021/jm050965z
11533398 75633 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
CHEMBL205447 75633 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 499 8 2 5 4.9 COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1 10.1021/jm050965z
16105876 136680 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 491 6 2 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL374979 136680 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 491 6 2 4 4.1 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CC3)CC2)c2ccccc12 10.1021/jm061118e
16105826 82763 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 578 9 2 6 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218366 82763 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 578 9 2 6 3.8 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)CCCN3CCOCC3)CC2)c2ccccc12 10.1021/jm061118e
16105820 141101 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 7 3 4 4.3 CCCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL385288 141101 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 7 3 4 4.3 CCCNC(=O)N1CCC(NS(=O)(=O)c2ccc(NC(=O)c3ccccc3C)c3ccccc23)CC1 10.1021/jm061118e
16105821 82759 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 6 3 4 4.3 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)NC(C)C)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL218350 82759 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 508 6 3 4 4.3 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)NC(C)C)CC2)c2ccccc12 10.1021/jm061118e
1099153 82729 10 None - 1 Human 5.1 pKi = 5.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 396 4 1 4 3.1 O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
CHEMBL218207 82729 10 None - 1 Human 5.1 pKi = 5.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 396 4 1 4 3.1 O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)c2ccccc12)c1ccccc1 10.1021/jm061118e
16105882 141463 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 527 6 2 4 5.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL387451 141463 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 527 6 2 4 5.0 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)c3ccccc3)CC2)c2ccccc12 10.1021/jm061118e
11685733 139672 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
CHEMBL380492 139672 0 None - 1 Human 8.1 pKi = 8.1 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 589 9 2 5 6.1 CC(C)(C(=O)O)N1CCC(C(=O)NC2CCN(Cc3cccc(Oc4ccccc4Cl)c3)CC2)(c2ccccc2)CC1 10.1021/jm050965z
16105804 82977 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 519 6 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
CHEMBL219433 82977 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 519 6 2 4 4.9 Cc1ccccc1C(=O)Nc1ccc(S(=O)(=O)NC2CCN(C(=O)C3CCCC3)CC2)c2ccccc12 10.1021/jm061118e
11329260 83823 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 487 6 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
CHEMBL221021 83823 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity to human CCR8 expressed in L1.2 cells by FMAT assayBinding affinity to human CCR8 expressed in L1.2 cells by FMAT assay
ChEMBL 487 6 2 5 3.8 CCOC(=O)N1CCC(NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)c3ccccc23)CC1 10.1021/jm061118e
11530171 75617 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 3.8 CCNC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL205304 75617 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 3.8 CCNC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
11681610 140055 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 4.0 CCC(=O)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z
CHEMBL381354 140055 0 None - 1 Human 5.0 pKi = 5.0 Binding
Displacement of [125I]I309 from human CCR8 expressed in L1.2 cellsDisplacement of [125I]I309 from human CCR8 expressed in L1.2 cells
ChEMBL 338 6 1 3 4.0 CCC(=O)NC1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 10.1021/jm050965z